A global survey of potential acceptance of a COVID-19 vaccine

• Published in: Nature medicine Vol. 27; no. 2; pp. 225 - 228
• Main Authors: Lazarus, Jeffrey V., Ratzan, Scott C., Palayew, Adam, Gostin, Lawrence O., Larson, Heidi J., Rabin, Kenneth, Kimball, Spencer, El-Mohandes, Ayman
• Format: Journal Article
• Language: English
• Published: New York Nature Publishing Group US 01.02.2021; Nature Publishing Group
• Subjects: 692/700/1538; 692/700/228; 692/700/478; Adolescent; Adult; Aged; Biomedical and Life Sciences; Biomedicine; Brief Communication; Cancer Research; Coronaviruses; COVID-19; COVID-19 - epidemiology; COVID-19 - immunology; COVID-19 - virology; COVID-19 vaccines; COVID-19 Vaccines - adverse effects; COVID-19 Vaccines - immunology; Female; Heterogeneity; Humans; Infectious Diseases; Internationality; Male; Metabolic Diseases; Middle Aged; Molecular Medicine; Neurosciences; Patient Acceptance of Health Care; Polls & surveys; Public health; Regression Analysis; SARS-CoV-2 - immunology; Surveys; Surveys and Questionnaires; Vaccines; Viral diseases; World health; Young Adult; United States

Several coronavirus disease 2019 (COVID-19) vaccines are currently in human trials. In June 2020, we surveyed 13,426 people in 19 countries to determine potential acceptance rates and factors influencing acceptance of a COVID-19 vaccine. Of these, 71.5% of participants reported that they would be ve...